Literature DB >> 17638090

Ibuprofen, the propionics and NSAIDs: personal reflections over four decades.

S S Adams1.   

Abstract

In 1952 I re-joined the Pharmacological Division of the Research Department of the Boots Co. in Nottingham UK to work on rheumatoid arthritis (RA) but with the distinct disadvantage that the Division was housed in a group of rambling buildings attached to a Victorian house. The Division had moved there at the beginning of World War II from the centre of Nottingham as a precaution against bombing - a wise move since part of the Research Department was destroyed in an air raid in 1941. Hence the first six years of my research was carried out under rather unfavourable conditions, for my laboratory was one of the two 'front' rooms of the house.

Entities:  

Year:  1999        PMID: 17638090     DOI: 10.1007/s10787-999-0002-3

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  3 in total

1.  [Antiphlogistic effect of pyrazols, especially of irgapyrin, in peroral and parenteral administration].

Authors:  G WILHELMI
Journal:  Schweiz Med Wochenschr       Date:  1950-09-02

Review 2.  Ibuprofen and paracetamol: relative safety in non-prescription dosages.

Authors:  K D Rainsford; S C Roberts; S Brown
Journal:  J Pharm Pharmacol       Date:  1997-04       Impact factor: 3.765

Review 3.  The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis.

Authors:  S Somasundaram; H Hayllar; S Rafi; J M Wrigglesworth; A J Macpherson; I Bjarnason
Journal:  Scand J Gastroenterol       Date:  1995-04       Impact factor: 2.423

  3 in total
  1 in total

1.  Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.

Authors:  Kalarickal Vijayan Dileep; Chandran Remya; Ignatius Tintu; Madathilkovilakathu Haridas; Chittalakkottu Sadasivan
Journal:  J Mol Model       Date:  2013-01-13       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.